Glycobiomedical products
Explore the glycoenzymes, activity assays, and substrate peptides we develop in our SCRU laboratories
Glycobiomedical Research & Commercialization Notice
The computational glycoscience models, cell-free biosynthesis platforms, and enzyme engineering technologies developed within the UCT Scientific Computing Research Unit (SCRU) are now commercialized, scaled, and distributed through our official university spin-out company, Struenodo (Pty) Ltd.
🔬 Products
Access our complete catalog of specialized glycoenzymes, high-throughput continuous activity
assays (UGC 2.0), and custom
substrate peptides.
💻 R&D Services
Leverage quantum molecular
modeling, AI-assisted inhibitor screening, custom carbohydrate biosynthesis, and analytical
validation pipelines tailored for your targets.
🤝 Industry & Academic Partnerships
Engage in co-development frameworks. We partner with agricultural, vaccine-development, and biotechnology firms globally to deploy next-gen glycotechnology.
Products and Services based on decades of academic research
The foundational research, peer-reviewed publications, and postgraduate training pipelines remain firmly anchored at the University of Cape Town. Commercial service agreements, supply logistics, and material transfer operations are managed through Struenodo to ensure institutional compliance and scalable quality control.